John A. Zaia

10.0k total citations · 2 hit papers
159 papers, 7.6k citations indexed

About

John A. Zaia is a scholar working on Epidemiology, Immunology and Oncology. According to data from OpenAlex, John A. Zaia has authored 159 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Epidemiology, 40 papers in Immunology and 39 papers in Oncology. Recurrent topics in John A. Zaia's work include Cytomegalovirus and herpesvirus research (91 papers), Herpesvirus Infections and Treatments (52 papers) and HIV Research and Treatment (33 papers). John A. Zaia is often cited by papers focused on Cytomegalovirus and herpesvirus research (91 papers), Herpesvirus Infections and Treatments (52 papers) and HIV Research and Treatment (33 papers). John A. Zaia collaborates with scholars based in United States, France and Chile. John A. Zaia's co-authors include Stephen J. Forman, John J. Rossi, Myron J. Levin, Michael Boeckh, Ghislaine Gallez‐Hawkins, Don J. Diamond, G. Schmidt, Joyce C. Niland, Edouard M. Cantin and Shirley Xin Li and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

John A. Zaia

157 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ribozymes as Potential Anti-HIV-1 Therapeutic Agents

1990 536 citations John A. Zaia, John J. Rossi et al. profile →
A Randomized, Controlled Trial of Prophylactic Ganciclovir for Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow Transplants

1991 485 citations John A. Zaia et al. profile →

Peers

Countries citing papers authored by John A. Zaia

Since Specialization

Citations

This map shows the geographic impact of John A. Zaia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Zaia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Zaia more than expected).

Fields of papers citing papers by John A. Zaia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Zaia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Zaia. The network helps show where John A. Zaia may publish in the future.

Co-authorship network of co-authors of John A. Zaia

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Zaia. A scholar is included among the top collaborators of John A. Zaia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Zaia. John A. Zaia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recurrent SARS-CoV-2 mutations at Spike D796 evade antibodies from pre-Omicron convalescent and vaccinated subjects 2024 ·Microbiology Spectrum ·Evan A. Elko, Heather Mead, (unknown), John A. Zaia, Jason T. Ladner, John A. Altin	6
2	Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity 2022 ·Blood Advances ·(unknown), Corinna La Rosa, Flavia Chiuppesi, Alfredo Puing, Ibrahim Aldoss, (unknown), Qiao Zhou, (unknown), (unknown), Teodora Kaltcheva, Daisy Johnson, (unknown), John A. Zaia, Ryotaro Nakamura, Monzr M. Al Malki, Don J. Diamond, Sanjeet Dadwal, Stephen J. Forman	3
3	High Incidence of CMV Reactivation after Haploidentical Donor Hematopoietic Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide, and Its Impact on Transplant Outcomes 2017 ·Blood ·Monzr M. Al Malki, Sanjeet Dadwal, Dongyun Yang, Sally Mokhtari, Thai M. Cao, Ketevan Gendzekhadze, Ibrahim Aldoss, Pablo Parker, Margaret O’Donnell, David S. Snyder, David Senitzer, Joseph Rosenthal, Auayporn Nademanee, Don J. Diamond, John A. Zaia, Stephen J. Forman, Ryotaro Nakamura	7
4	MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults 2016 ·Blood ·Corinna La Rosa, Jeff Longmate, Joy Martinez, Qiao Zhou, Teodora Kaltcheva, Weimin Tsai, (unknown), Mary Carroll, Felix Wussow, Flavia Chiuppesi, Nicola Hardwick, Sanjeet Dadwal, Ibrahim Aldoss, Ryotaro Nakamura, John A. Zaia, Don J. Diamond	58
5	CMVpp65 Vaccine Enhances the Antitumor Efficacy of Adoptively Transferred CD19-Redirected CMV-Specific T Cells 2015 ·Clinical Cancer Research ·Xiuli Wang, ChingLam W. Wong, Ryan Urak, Armen Mardiros, Lihua E. Budde, Wen-Chung Chang, Sandra H. Thomas, Christine E. Brown, Corinna La Rosa, Don J. Diamond, Michael C. Jensen, Ryotaro Nakamura, John A. Zaia, Stephen J. Forman	52
6	A Novel Class of HIV-1 Antiviral Agents Targeting HIV via a SUMOylation-Dependent Mechanism 2015 ·Scientific Reports ·Ikenna G. Madu, Shirley Xin Li, Baozong Li, Haitang Li, Tammy T. Chang, Yijia Li, (unknown), John J. Rossi, Jiing‐Kuan Yee, John A. Zaia, Yuan Chen	12
7	Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial 2015 ·The Lancet Haematology ·Ryotaro Nakamura, Corinna La Rosa, Jeff Longmate, (unknown), (unknown), Qiao Zhou, (unknown), Margaret O’Donnell, (unknown), Len Farol, Amandeep Salhotra, David S. Snyder, Ibrahim Aldoss, Stephen J. Forman, Jeffrey S. Miller, John A. Zaia, Don J. Diamond	57
8	Donor killer immunoglobulin-like receptor genes and reactivation of cytomegalovirus after HLA-matched hematopoietic stem-cell transplantation: HLA-C allotype is an essential cofactor 2013 ·Frontiers in Immunology ·Carolyn E. Behrendt, Ryotaro Nakamura, Stephen J. Forman, John A. Zaia	10
9	Considerations for the Clinical Application of Chimeric Antigen Receptor T Cells: Observations from a Recombinant DNA Advisory Committee Symposium Held June 15, 2010 2011 ·Cancer Research ·Hildegund C.J. Ertl, John A. Zaia, Steven A. Rosenberg, Carl H. June, Gianpietro Dotti, Jeffrey Kahn, Laurence J.N. Cooper, Jacqueline Corrigan‐Curay, Scott E. Strome	57
10	Cytomegalovirus Viral Load and Virus-Specific Immune Reconstitution after Peripheral Blood Stem Cell versus Bone Marrow Transplantation 2011 ·Biology of Blood and Marrow Transplantation ·Abraham Guerrero, Stanley R. Riddell, Jan Storek, Terry Stevens‐Ayers, Barry E. Storer, John A. Zaia, Stephen J. Forman, Robert S. Negrin, Thomas R. Chauncey, William Bensinger, Michael Boeckh	22
11	Functional Comparison of T Cells Recognizing Cytomegalovirus pp65 and Intermediate‐Early Antigen Polypeptides in Hematopoietic Stem‐Cell Transplant and Solid Organ Transplant Recipients 2006 ·The Journal of Infectious Diseases ·Simon F. Lacey, Corinna La Rosa, Wendy Zhou, (unknown), Joy Martinez, Aparna Krishnan, Ghislaine Gallez‐Hawkins, Lia Thao, Jeff Longmate, Ricardo Spielberger, Stephen J. Forman, Ajit P. Limaye, John A. Zaia, Don J. Diamond	42
12	DNA and low titer, helper-free, recombinant AAV prime-boost vaccination for cytomegalovirus induces an immune response to CMV-pp65 and CMV-IE1 in transgenic HLA A0201 mice 2004 ·Vaccine* ·Ghislaine Gallez‐Hawkins, Xiuli Li, Anne Franck, Lia Thao, Simon F. Lacey, Don J. Diamond, John A. Zaia	16
13	Lack of association of cytomegalovirus with human brain tumors 2004 ·Modern Pathology ·Sean K. Lau, Yuanyuan Chen, (unknown), Don J. Diamond, Adam N. Mamelak, John A. Zaia, Lawrence M. Weiss	92
14	Stem Cell Transplantation and Gene Therapy for HIV-Related Lymphomas 2002 ·Journal of Hematotherapy & Stem Cell Research ·Amrita Krishnan, John A. Zaia, Arturo Molina	9
15	PLASMA POLYMERASE CHAIN REACTION FOR CYTOMEGALOVIRUS DNA AFTER ALLOGENEIC MARROW TRANSPLANTATION 1997 ·Transplantation ·Michael Boeckh, Ghislaine Gallez‐Hawkins, David Myerson, John A. Zaia, Raleigh A. Bowden	114
16	Molecular and epidemiologic evaluations of a cluster of cases of Ménétrièrʼs disease associated with cytomegalovirus 1993 ·The Pediatric Infectious Disease Journal ·Andrea Kovacs, (unknown), David L. Wood, Laurene Mascola, John A. Zaia	20
17	Ribozymes as Anti-HIV-1 Therapeutic Agents: Principles, Applications, and Problems 1992 ·AIDS Research and Human Retroviruses ·John J. Rossi, David A. Elkins, John A. Zaia, Seán M. Sullivan	62
18	Exploring the Use of Antisense, Enzymatic RNA Molecules (Ribozymes) as Therapeutic Agents 1991 ·PubMed ·John J. Rossi, David A. Elkins, (unknown), John A. Zaia, Seán M. Sullivan, James O. Deshler	10
19	Confirmation of HIV Infection Using Gene Amplification 1989 ·Transfusion Medicine Reviews ·John A. Zaia, John J. Rossi	2
20	Genomic localization of the gene encoding a 32-kDa capsid protein of human cytomegalovirus 1988 ·Virology ·Hema Pande, (unknown), (unknown), Brian R. Clark, John A. Zaia	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact